Reporting adverse events of ChAdOx1 nCoV-19 coronavirus vaccine (Recombinant) among the vaccinated healthcare professionals: A cross-sectional survey

被引:10
|
作者
Kaur, Sukhpal [1 ]
Singh, Ajay [2 ]
Saini, Sushma [1 ]
Rohilla, Latika [1 ]
Kaur, Jasvir [1 ]
Chandi, Anadeep [3 ]
Kaur, Gurpreet [1 ]
Singh, Manjeet [9 ]
Kumar, Pramod [1 ]
Soni, Shiv Lal [10 ]
Kajal, Kamal [2 ]
Naik, Naveen B. [2 ]
Malhotra, Pankaj [4 ]
Verma, Sanjay [5 ]
Gupta, Madhu [6 ]
Devnani, Mahesh [7 ]
Das, Karobi [1 ]
Pandav, S. S. [8 ]
Puri, G. D. [2 ]
机构
[1] Govt Multispecial Hosp, Natl Inst Nursing Educ, Dept Nursing, Chandigarh, India
[2] Govt Multispecial Hosp, Dept Anaesthesia & Intens Care, Chandigarh, India
[3] Govt Multispecial Hosp, Dept Obstet & Gynaecol, Chandigarh, India
[4] Govt Multispecial Hosp, Dept Internal Med, Chandigarh, India
[5] Govt Multispecial Hosp, Dept Paediat, Chandigarh, India
[6] Govt Multispecial Hosp, Dept Community Med, Chandigarh, India
[7] Govt Multispecial Hosp, Hosp Adm, Chandigarh, India
[8] Multispecial Hosp, Postgrad Inst Med Educ & Res, Ophthalmol, Chandigarh, India
[9] Govt Multispecial Hosp, Dept Med, Chandigarh, India
[10] Postgrad Inst Med Educ & Res, Dept Anaesthesia & Intens Care, Sect 12, Chandigarh 160012, India
关键词
Adverse events; ChAdOx1; nCoV-19; coronavirus disease 2019; healthcare professionals; side effects; vaccination;
D O I
10.4103/ijmr.ijmr_1221_21
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: The safety of the ChAdOx1 nCoV-19 vaccine is a cause of concern for many who have been vaccinated. The people have multiple concerns and fear regarding the adverse events of the vaccine. Thus, this study was undertaken to establish the safety profile of ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) among the healthcare professionals. Methods: This was a descriptive cross-sectional survey. After taking clearance from the institutional ethics committee 1500 healthcare professionals, who had their vaccination in the past two weeks were selected. They were provided with an online survey proforma regarding adverse events following immunization (AEFIs) of COVID-19 vaccine developed using google forms with an informed consent form affixed to it. Results: A total of 1036 individuals participated in the study. The mean and median (inter quartile range) age of the participants was 37.7 +/- 11.25 and 35 (29-46) yr, respectively. Of these, 52.1 per cent were female, 29.3 per cent were doctors, 33.4 per cent were nurses and 9.5 per cent were paramedical staff. Forty six per cent participants experienced one or more minor AEFIs such as pain, tenderness, redness, etc. at the injection site. Fatigue (31.75%), generalized feeling of unwell (28.57%), muscle pain (23.16%) and fever (21.71%) were the most commonly reported systemic AEFIs followed by headache (20.07%), dizziness (10.03%) and joint pains (15.25%). Most of them experienced these AEFIs within 24 h of the first dose of administration. About 42 per cent of the participants took oral antipyretics/analgesics for managing the AEFIs. Interpretation & conclusions: ChAdOx1 nCoV-19 Corona Virus Vaccine was found to be associated with mild local and systemic AEFIs that were more common after the first dose as compared to the second dose. There adverse events could be dealt with oral over-the-counter medications, with no requirement of hospitalization.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 50 条
  • [1] Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine
    Huh, Kyungmin
    Na, Yewon
    Kim, Young-Eun
    Radnaabaatar, Munkhzul
    Peck, Kyong Ran
    Jung, Jaehun
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (27) : 1 - 6
  • [2] Active Symptom-Based Surveillance of Adverse Events Following Immunization Among Individuals Vaccinated with ChAdOx1 nCoV-19 Coronavirus Vaccine in a Tertiary Hospital of Kerala
    Jose, Maria
    Rajmohan, Priyanka
    Thomas, Joe
    Krishna, Swathi
    Antony, Beena
    Gopinathan, Unnikrishnan U.
    Iyyapan, Elsy M.
    Porinchu, Raphael M.
    Jose, Ponnu
    Raphael, Lucy
    Kuttichira, Praveenlal
    CURRENT DRUG SAFETY, 2022, 17 (04) : 327 - 334
  • [3] Adverse Events Following Immunization Associated with the First and Second Doses of the ChAdOx1 nCoV-19 Vaccine among Healthcare Workers in Korea
    Jeon, Minji
    Kim, Jehun
    Oh, Chi Eun
    Lee, Jin-Young
    VACCINES, 2021, 9 (10)
  • [4] Reactogenicity and Immunogenicity of the ChAdOx1 nCOV-19 Coronavirus Disease 2019 Vaccine in South Korean Healthcare Workers
    Hyun, JongHoon
    Park, Yongjung
    Song, Young Goo
    Han, Sang Hoon
    Park, Soon Young
    Kim, Sin Hye
    Park, Ji Su
    Jeon, So Young
    Lee, Hye Sun
    Lee, Kyoung Hwa
    YONSEI MEDICAL JOURNAL, 2022, 63 (12) : 1078 - 1087
  • [5] Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021
    Konu, Yao Rodion
    Gbeasor-Komlanvi, Fifonsi Adjidossi
    Yerima, Mouhoudine
    Sadio, Arnold Junior
    Tchankoni, Martin Kouame
    Zida-Compaore, Wendpouire Ida Carine
    Nayo-Apetsianyi, Josee
    Afanvi, Kossivi Agbelenko
    Agoro, Sibabe
    Salou, Mounerou
    Landoh, Dadja Essoya
    Nyansa, Atany B.
    Boko, Essohanam
    Mijiyawa, Moustafa
    Ekouevi, Didier Koumavi
    ARCHIVES OF PUBLIC HEALTH, 2021, 79 (01)
  • [6] ChAdOx1 nCoV-19 Vaccine Side Effects among Healthcare Workers in Trinidad and Tobago
    Gopaul, Chavin D.
    Ventour, Dale
    Thomas, Davlin
    VACCINES, 2022, 10 (03)
  • [7] Adverse events following immunization of ChAdOx1 nCoV-19 vaccine among healthcare workers of a medicine-teaching institution of North India
    Jha, Abhinav
    Kumar, Pankaj
    Goel, Shelesh K.
    Bharatwal, Apoorv A.
    Dhamnetiya, Deepak
    Singh, Saurabh
    Jha, Ravi P.
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (01) : 298 - 310
  • [8] Comparing ChAdOx1 nCoV-19 Coronavirus Vaccine (Recombinant) (Covishield) and BBV152; Bharat Biotech COVID-19 Vaccine (Covaxin) for COVID-19: Reports of Adverse Events Following Vaccination among the Indian Population
    Kaur, Sukhpal
    Rohilla, Latika
    Kayina, Choro Athiphro
    Kaur, Jasvir
    Kaur, Gurpreet
    Walia, Anjani
    Kumar, Pramod
    Singh, Ajay
    Saini, Sushma
    Soni, Shiv Lal
    Malhotra, Pankaj
    INDIAN JOURNAL OF PUBLIC HEALTH, 2025, 69 (01) : 27 - 32
  • [9] Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV-19 corona virus vaccine (recombinant)
    Sandhu, Sunmeet
    Bhatnagar, Anuj
    Kumar, Harish
    Dixit, Prashant Kumar
    Paliwal, Gourang
    Suhag, Devinder Kumar
    Patil, Chetan
    Mitra, Debdeep
    DERMATOLOGIC THERAPY, 2021, 34 (06)
  • [10] ChAdOx1 nCoV-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome among Adults: A Systematic Review
    Faghihi, Homa
    Mottaghi-Dastjerdi, Negar
    Sharifzadeh, Mohammad
    Kakavandi, Nader Rahimi
    ADVANCED PHARMACEUTICAL BULLETIN, 2023, 13 (04) : 723 - 735